Sentinel lymph node biopsy in endometrial and cervical cancer: current and controversial issues

The authors review the controversial issues regarding the management algorithms, the impact of ultrastaging to adjuvant treatment, and outcomes from the role of sentinel lymph nodes (SLN) in endometrial cancer (EC) and cervical cancer (CC). According to standard recommendation, side specific nodal resection is required in case of failed mapping. Alternative algorithms were proposed to reduce overtreatment in low risk EC and CC. The positive results of new algorithms may lead to a proper selection of patients in which pelvic lymphadenectomy could be avoided. Ultrastaging had an impact on accuracy by increasing the detection rate by 25-50%. Occult LN metastasis was associated with myometrial invasion in EC, but the relationships between other known factors of CC recurrence are un-clear. Prognosis for the patient with either EC or CC in SLN algorithm group was similar to those in the lymphadenectomy group while the latter group had shown a higher surgical morbidity.

Algorithm; Cervical cancer; Endometrial cancer; Outcome; Sentinel lymph node; Ultrastaging.

[1] National Comprehensive Cancer Network: “Uterine Neoplasm (Ver-sion 1.2018)”. Available at: https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf

[2] Barlin J.N., Khoury-Collado F., Kim C.H., Leitao M.M, Jr., Chi D.S., Sonoda Y., et al.: “The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes”. Gynecol Oncol., 2012, 125, 531.

[3] Sinno A.K., Peijnenburg E., Fader A.N., Temkin S.M., Stone R., Levinson K., et al.: ”Reducing overtreatment: A comparison of lymph node assessment strategies for endometrial cancer”. Gynecol. Oncol., 2016, 143, 281.

[4] Tanner E., Puechl A., Levinson K., Havrilesky L.J., Sinno A., Secord A. A., et al.: “Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endome-trial cancer”. Gynecol. Oncol., 2017, 147, 535.

[5] Cormier B, Diaz JP, Shih K, Sampson RM, Sonoda Y, Park KJ, et al.: “Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer”. Gynecol Oncol., 2011, 122, 275.

[6] National Comprehensive Cancer Network: “Cervical Cancer (Ver-sion 1.2017)”. Available at: https://www.nccn.org/professionals/physician_gls/PDF/cervical.pdf.

[7] Fagotti A., Pedone Anchora L., Conte C., Chiantera V., Vizza E., Tor-torella L., et al.: “Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients”. Cancer Med., 2016, 5, 1725.

[8] Ferrandina G., Pedone Anchora L., Gallotta V., Fagotti A., Vizza E., Chiantera V., et al.: “Can We Define the Risk of Lymph Node Metas-tasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Ret-rospective Study”. Ann. Surg. Oncol., 2017, 24, 2311.

[9] Ballester M., Dubernard G., Lecuru F., Heitz D., Mathevet P., Marret H., et al.: “Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)”. Lancet Oncol., 2011, 12, 469.

[10] Khoury-Collado F., Murray M.P., Hensley M.L., Sonoda Y., Alektiar K. M., Levine D.A., et al.: “Sentinel lymph node mapping for en-dometrial cancer improves the detection of metastatic disease to re-gional lymph nodes”. Gynecol. Oncol., 2011, 122, 251.

[11] Desai P.H., Hughes P., Tobias D.H., Tchabo N., Heller P.B., Dise C., et al.: “Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC)”. Gynecol Oncol. 2014, 135, 196.

[12] Naoura I., Canlorbe G., Bendifallah S., Ballester M., Darai E.: “Rel-evance of sentinel lymph node procedure for patients with high-risk endometrial cancer”. Gynecol. Oncol., 2015, 136, 60.

[13] Hagen B., Valla M., Aune G., Ravlo M., Abusland A.B., Araya E., et al.: “Indocyanine green fluorescence imaging of lymph nodes dur-ing robotic-assisted laparoscopic operation for endometrial cancer. A prospective validation study using a sentinel lymph node surgical algorithm”. Gynecol. Oncol., 2016, 143, 479.

[14] How J., Gotlieb W.H., Press J.Z., Abitbol J., Pelmus M., Ferenczy A., et al.: “Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer”. Gynecol. Oncol. 2015, 137, 436.

[15] Liu C.Y., Elias K.M., Howitt B.E., Lee L.J., Feltmate C.M.: “Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study:. Gynecol. Oncol., 2017, 145, 248.

[16] Paley P.J., Veljovich D.S., Press J.Z., Isacson C., Pizer E., Shah C.: “A prospective investigation of fluorescence imaging to detect sen-tinel lymph nodes at robotic-assisted endometrial cancer staging”. Am. J. Obstet. Gynecol. 2016, 215, 117.

[17] Altgassen C., Muller N., Hornemann A., Kavallaris A., Hornung D., Diedrich K., et al.: “Immunohistochemical workup of sentinel nodes in endometrial cancer improves diagnostic accuracy”. Gynecol. Oncol., 2009, 114, 284.

[18] Abu-Rustum NR.: “Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging”. J. Nat. Compr. Canc. Netw., 2014, 12, 288.

[19] Cibula D., Zikan M., Slama J., Fischerova D., Kocian R., Germanova A., et al.: “Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer”. Gynecol. Oncol., 2016, 143, 83.

[20] Kim C.H., Soslow R.A., Park K.J., Barber E.L., Khoury-Collado F., Barlin J.N., et al.: “Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer stag-ing”. Int. J. Gynecol. Cancer, 2013, 23, 964.

[21] Erkanli S., Bolat F., Seydaoglu G.: “Detection and importance of mi-crometastases in histologically negative lymph nodes in endometrial carcinoma”. Eur. J. Gynaecol. Oncol., 2011, 32, 619.

[22] McCoy A., Finan M.A., Boudreaux F.T., Tucker J.A., Lazarchick J..J., Donnell R.M., et al.: “The incidence and clinical significance of lymph node micrometastases determined by immunohistochemi-924 cal staining in stage I - lymph node negative endometrial cancer”. Histol. Histopathol., 2012, 27, 181.

[23] St Clair C.M., Eriksson A.G., Ducie J.A., Jewell E.L., Alektiar K.M., Hensley M.L., et al.: “Low-Volume Lymph Node Metastasis Dis-covered During Sentinel Lymph Node Mapping for Endometrial Carcinoma”. Ann. Surg. Oncol., 2016, 23, 1653.

[24] Plante M., Stanleigh J., Renaud M.C., Sebastianelli A., Grondin K., Gregoire J.: “Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: Does adjuvant treatment matter?” Gynecol Oncol., 2017, 146, 240.

[25] Todo Y., Kato H., Okamoto K., Minobe S., Yamashiro K., Sakuragi N.: “Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer”. J. Gynecol. Oncol., 2016, 27, e1.

[26] Wu Y., Li Z., Wu H., Yu J.: “Sentinel lymph node biopsy in cervical cancer: A meta-analysis”. Mol. Clin. Oncol., 2013, 1, 1025.

[27] Lentz S.E., Muderspach L.I., Felix J.C., Ye W., Groshen S., Amezcua C. A.: “Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients”. Obstet. Gy-necol., 2004, 103, 1204.

[28] Stany M.P., Stone P.J., Felix J.C., Amezcua C.A., Groshen S., Ye W., et al.: “Lymph Node Micrometastases in Early-Stage Cervical Can-cer are Not Predictive of Survival”. Int. J. Gynecol. Pathol., 2015, 34, 379.

[29] Colturato L.F., Signorini Filho R.C., Fernandes R.C., Gebrim L.H., Oliani A.H.: “Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence”. Int. J. Gynaecol. Obstet., 2016, 133, 69.

[30] Cibula D., Abu-Rustum N.R., Dusek L., Slama J., Zikan M., Zaal A., et al.: “Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis”. Gynecol. Oncol., 2012, 127, 462.

[31] Horn L.C., Hentschel B., Fischer U., Peter D., Bilek K.: “Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: Frequency, topographic dis-tribution and prognostic impact”. Gynecol. Oncol., 2008, 111, 276.

[32] Leitao M.M., Jr., Khoury-Collado F., Gardner G., Sonoda Y., Brown C. L., Alektiar KM, et al.: “Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive pro-cedures on the detection of stage IIIC endometrial cancer”. Gynecol. Oncol., 2013, 129, 38.

[33] Dari E, Dubernard G., Bats A.S., Heitz D., Mathevet P., Marret H., et al.: “Sentinel node biopsy for the management of early stage en-dometrial cancer: long-term results of the SENTI-ENDO study”. Gy-necol. Oncol., 2015, 136, 54.

[34] Zahl Eriksson A.G., Ducie J., Ali N., McGree M.E., Weaver A.L., Bogani G., et al.: “Comparison of a sentinel lymph node and a se-lective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion”. Gynecol. Oncol., 2016, 140, 394.

[35] Lennox G.K., Covens A.: “Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?” Gynecol. Oncol., 2017, 144, 16.

[36] Mathevet P., Lecuru F., Magaud L., Bouttitie F.: “Sentinel lymph node biopsy for early cervical cancer: Results of a randomized prospective, multicenter study (Senticol 2) comparing adding pelvic lymph node dissection vs sentinel node biopsy only”. Gynecol. Oncol., 2017, 145, 2.

[37] Niikura H., Okamoto S., Otsuki T., Yoshinaga K., Utsunomiya H., Nagase S., et al.: “Prospective study of sentinel lymph node biopsy without further pelvic lymphadenectomy in patients with sentinel lymph node-negative cervical cancer. International journal of gyne-cological cancer”. Int. J. Gynecol. Cancer., 2012, 22, 1244.